Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-08

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating umbilical cord mesenchymal stem cells for liver cirrhosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED